LiviWell Secured FDA Clearance for Livi, Introducing a New Category in Post-Intercourse Vaginal Care
On 24 March 2026, LiviWell announced that the U.S. Food and Drug Administration had granted clearance for Livi, a novel device developed to support vaginal health by absorbing semen and other post-intercourse fluids.
This regulatory approval represented a key milestone for the company, positioning Livi as a first-of-its-kind solution in the intimate health space. The device was designed for vaginal insertion after intercourse, where it functioned to quickly absorb fluids, typically within about 60 seconds. It was constructed from soft polyurethane foam and ...
